SPOTLIGHT -
Investigation into the safety and efficiency of using AquaLase
Study: Children with vision impairment have reduced quality of life
Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems
Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections
RETFound: New AI model to detect retinal disease biomarkers developed by Moorfields Eye Hospital
The AI retinal scanning model will be free to use for all institutions
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
Syncona announces Novartis will discontinue development of GT005 for geographic atrophy
Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022
Bausch + Lomb launches MIEBO (perfluorohexyloctane ophthalmic solution) in US
According to Bausch + Lomb, MIEBO (perfluorohexyloctane ophthalmic solution), commercialised as EvoTears in Europe, is the first prescription eye drop that targets tear evaporation.
